Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Tese de Doutorado
|
![]() |
Efeitos de hipolipemiantes sobre a expressão de CYP3A4 e CYP3A5 in vitro e in vivoWillrich, Maria Alice VieiraBiblioteca Digital de Teses e Dissertações da USP; Universidade de São Paulo; Faculdade de Ciências Farmacêuticas 2011-10-07Acesso online. A biblioteca também possui exemplares impressos. |
2 |
Material Type: Artigo
|
![]() |
The impact of CYP3A5 3 polymorphism on sirolimus pharmacokinetics: insights from predictions with a physiologically‐based pharmacokinetic modelEmoto, Chie ; Fukuda, Tsuyoshi ; Venkatasubramanian, Raja ; Vinks, Alexander A.British journal of clinical pharmacology, 2015-12, Vol.80 (6), p.1438-1446 [Periódico revisado por pares]Texto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Association of CYP3A41B, CYP3A422 and CYP3A53 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasiaAbdullaev, Sh. P. ; Shatokhin, M. N. ; Sigailo, O. L. ; Abdullaev, Sh. P. ; Bochkov, P. O. ; Tuchkova, S. N. ; Teodorovich, O. V. ; Loran, O. B. ; Sychev, D. A.Farmaciâ i Farmakologiâ (Pâtigorsk), 2024-05, Vol.12 (1), p.32-48 [Periódico revisado por pares]Texto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Comparison of the Stimulatory and Inhibitory Effects of Steroid Hormones and α-Naphthoflavone on Steroid Hormone Hydroxylation Catalyzed by Human Cytochrome P450 3A SubfamiliesToshiro Niwa ; Manami Toyota ; Hinako Kawasaki ; Risa Ishii ; Shoko SasakiBiological and Pharmaceutical Bulletin, 2021-04, Vol.44 (4), p.579-584 [Periódico revisado por pares]Pharmaceutical Society of JapanTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Effect of CYP3A422 and CYP3A41B but not CYP3A53 polymorphisms on tacrolimus pharmacokinetic model in Tunisian kidney transplantHannachi, Ibtissem ; Ben Fredj, Nadia ; Chadli, Zohra ; Ben Fadhel, Najah ; Ben Romdhane, Haifa ; Touitou, Yvan ; Boughattas, Naceur A. ; Chaabane, Amel ; Aouam, KarimToxicology and applied pharmacology, 2020-06, Vol.396, p.115000, Article 115000 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of VoriconazoleJia, Su-jie ; Gao, Ke-qin ; Huang, Pan-hao ; Guo, Ren ; Zuo, Xiao-cong ; Xia, Qing ; Hu, Shuang-yao ; Yu, Zhen ; Xie, Yue-liangFrontiers in pharmacology, 2021-05, Vol.12, p.666296-666296 [Periódico revisado por pares]Frontiers Media S.ATexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocritJonge, Hylke ; Vanhove, Thomas ; Loor, Henriëtte ; Verbeke, Kristin ; Kuypers, Dirk R. J.British journal of clinical pharmacology, 2015-09, Vol.80 (3), p.548-559 [Periódico revisado por pares]England: John Wiley & Sons, LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamiliesNiwa, Toshiro ; Okamoto, Ayaka ; Narita, Kanae ; Toyota, Manami ; Kato, Kyoko ; Kobayashi, Kyoko ; Sasaki, ShokoArchives of biochemistry and biophysics, 2020-03, Vol.682, p.108283-108283, Article 108283 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Structural characterization of the homotropic cooperative binding of azamulin to human cytochrome P450 3A5Hsu, Mei-Hui ; Johnson, Eric F.The Journal of biological chemistry, 2022-05, Vol.298 (5), p.101909, Article 101909 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Influence of genetic variants on the pharmacokinetics and pharmacodynamics of sirolimus: a systematic reviewWm Te Loo, D Maroeska ; Harbers, Veroniek ; Vermeltfoort, Lars ; Coenen, Marieke JhPharmacogenomics, 2023-07, Vol.24 (11), p.629-639 [Periódico revisado por pares]England: Future Medicine LtdTexto completo disponível |